Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (261-270 of 315) with videos related to

Pageof 32
Sort By:
Annals of Surgical Oncology|September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free SurvivalCallisia N Clarke, Michael S Lee, Wei Wei, et al.
Lancet (London, England)|October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trialJ Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2017
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicityRanda Tao, Chiaojung Jillian Tsai, Garrett Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2017
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline UpdatePaul J Hesketh, Mark G Kris, Ethan Basch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
JAMA Network Open|November 12, 2024
Patient-Reported Discussions on Fertility Preservation Before Early-Onset Cancer TreatmentSamantha R Keller, Allison Rosen, Mark A Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Oncotarget|June 4, 2021
CEA as a blood-based biomarker in anal cancerRobert Hester, Shailesh Advani, Asif Rashid, et al.
Pageof 32

Showing results (261-270 of 315) with videos related to

Sort By:
Pageof 32
Annals of Surgical Oncology|September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free SurvivalCallisia N Clarke, Michael S Lee, Wei Wei, et al.
Lancet (London, England)|October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trialJ Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2017
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicityRanda Tao, Chiaojung Jillian Tsai, Garrett Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2017
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline UpdatePaul J Hesketh, Mark G Kris, Ethan Basch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
JAMA Network Open|November 12, 2024
Patient-Reported Discussions on Fertility Preservation Before Early-Onset Cancer TreatmentSamantha R Keller, Allison Rosen, Mark A Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Oncotarget|June 4, 2021
CEA as a blood-based biomarker in anal cancerRobert Hester, Shailesh Advani, Asif Rashid, et al.
Pageof 32